Evidence map›Paper›PMID 41888121›Full record

ArticleNPJ genomic medicine2026

Completely resolved structural variants by optical genome mapping with adaptive sampling from CNV discovery.

Li Fu, Chong Ae Kim, Masatoshi Tokita, Yohane Miyata, Nobuhiko Okamoto, Yoshio Makita, Hitoshi Osaka, Ayataka Fujimoto, Atsuro Daida, Jun Nirei and 27 more

Abstract read
In one paragraph

Article in NPJ genomic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Li FuDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Chong Ae KimGenetics Unit, Instituto da Crianca, Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
Masatoshi TokitaDepartment of Pediatrics, Kyorin University School of Medicine, Tokyo, Japan.
Yohane MiyataDepartment of Pediatrics, Kyorin University School of Medicine, Tokyo, Japan.
Nobuhiko OkamotoDepartment of Medical Genetics, Osaka Women's and Children's Hospital, Osaka, Japan.
Yoshio MakitaDepartment of Genetic Counseling, Asahikawa Medical University Hospital, Asahikawa, Japan.
Hitoshi OsakaDepartment of Pediatrics, Jichi Medical University, Shimotsuke, Japan.
Ayataka FujimotoComprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Atsuro DaidaDivision of Neurology, Saitama Children's Medical Center, Saitama, Japan.
Jun NireiDepartment of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Noriko UdagawaDepartment of Pediatrics, St. Marianna University School of Medicine, Kawasaki, Japan.
Seiichi HayakawaDepartment of Pediatrics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Kimiko DeguchiDeguchi Pediatric Clinic, Omura, Japan.
Mitsumasa FukudaDepartment of Neuropediatrics, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.
Hiroshi MatsumotoDepartment of Pediatrics, Saitama Medical University Hospital, Saitama, Japan.
Manami AkasakaDepartment of Pediatrics, Iwate Medical University School of Medicine, Yahaba, Japan.
Junichiro OkadaDivision of Neonatology, St. Mary's Hospital, Fukuoka, Japan.
Yohei MisumiDepartment of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Jun KidoDepartment of Pediatrics, Kumamoto University Hospital, Kumamoto, Japan.
Toshifumi SuzukiDepartment of Obstetrics and Gynecology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Hiromi AoiDepartment of Obstetrics and Gynecology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Rie SeyamaDepartment of Obstetrics and Gynecology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Haruka HamanoueDepartment of Clinical Genetics, Yokohama City University Hospital, Yokohama, Japan.
Satomi MitsuhashiDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Sachiko OhoriDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Ken SaidaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Yuta InoueDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Kohei HamanakaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Naomi TsuchidaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Yuri UchiyamaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Eriko KoshimizuDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Satoko MiyatakeDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Takeshi MizuguchiDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Atsuo ItakuraDepartment of Obstetrics and Gynecology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Naoki HaradaDepartment of Fundamental Cell Technology, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
Atsushi FujitaDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Naomichi MatsumotoDepartment of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama, Japan. naomat@yokohama-cu.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Structural variants (SVs), including duplications, deletions, inversions, translocations, and insertions, play major roles in human phenotypic diversity but remain difficult to detect because of variable size and structural complexity. Optical genome mapping (OGM) uses ultra-high molecular weight DNA (>150 kb) fluorescently labeled at a specific six-nucleotide sequence, enabling comprehensive SV detection by analyzing labeling patterns along long DNA molecules. This study aimed to fully characterize SVs using OGM. OGM was applied to 30 cases with exome sequencing-based copy number (CN) variants (16 CN losses, 7 CN gains, and 7 combined CN losses and gains). Additionally, targeted Oxford Nanopore long-read sequencing with adaptive sampling was used to determine breakpoints of SVs. This approach revealed undetected SVs in 14 cases (46.7%), and disclosed gene disruptions or CN alterations explaining clinical features in seven cases (23.3%). Even complex SVs involving numerous chromosomal segments and breakpoints were resolved efficiently, highlighting the power of combining OGM and long-read sequencing. Integrating OGM with long-read sequencing improves diagnostic resolution beyond sequencing alone and provides a robust framework for interpreting complex SVs. These findings highlight the potential clinical utility of combining OGM and long-read sequencing as a comprehensive diagnostic strategy for improved precision medicine in rare genetic diseases.

Identifiers

PMID41888121
PMCPMC13184285

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.